Evolution of low density lipoprotein structure probed with monoclonal antibodies.
To assess the relationship of apoB structures in different species of animals, the expressions of apoB epitopes in the sera or plasmas of 23 different mammalian species and one marsupial, and on the low density lipoprotein (LDL) from three species of apes, six species of monkeys, and eight non-primates were measured in competitive radioimmunoassays. The abilities of the sera or LDL to compete with 125I-labeled human LDL for binding to seven monoclonal antihuman LDL antibodies immobilized on microtiter plates were determined. LDL of apes bound to most antibodies, while monkey LDL bound to two or three antibodies. Other mammalian LDL bound only weakly to two of the antibodies or to none. The two monoclonal antibodies binding the LDL of more species were those antibodies which also inhibited the binding to and degradation of LDL by human fibroblasts. The rank order of binding of the LDL of a given species to the antibodies correlated with the rank order inhibition of binding and degradation of 125I-labeled human LDL in the human fibroblast system. This suggests that epitopes spatially located near the recognition site of apoB for cellular receptors have a greater tendency to be conserved.
D000818:Animals; D000911:Antibodies, Monoclonal; D001055:Apolipoproteins B / Q000276:immunology* / Q000378:metabolism; D001667:Binding, Competitive; D005075:Biological Evolution; D000939:Epitopes / Q000276:immunology; D006801:Humans; D007120:Immunochemistry; D008077:Lipoproteins, LDL / Q000276:immunology; D011323:Primates / Q000276:immunology; D014714:Vertebrates / Q000276:immunology
D000911:Antibodies, Monoclonal; D001055:Apolipoproteins B; D000939:Epitopes; D008077:Lipoproteins, LDL